Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Footer revision label updated from v3.5.4 to v3.5.5, indicating a deployment of a newer page template. No visible changes to the page content or user-facing features.
    Difference
    0.1%
    Check dated 2026-06-08T14:47:46.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.3 to v3.5.4, indicating a site deployment or maintenance update. This does not change the study content or visible page information.
    Difference
    0.1%
    Check dated 2026-05-18T03:50:04.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The site revision indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3** on the study details page.
    Difference
    0.1%
    Check dated 2026-04-26T08:18:46.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision changed from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T01:28:52.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:30:27.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T19:04:10.000Z thumbnail image

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.